India flags Abhayrab rabies vaccine batch as substandard, investigates if spurious

India has flagged a batch of the Abhayrab rabies vaccine as substandard and launched a probe to determine if the vaccine is spurious, according to official documents reviewed by Reuters.

The investigation centres on the quality and authenticity of the vaccine batch in question. Rabies vaccines are critical public health products, and any concerns over their integrity raise significant safety implications for recipients.

Authorities are examining whether the batch meets required manufacturing and quality standards or if it may be counterfeit.